Advisor Group Holdings »

Protagenic Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Protagenic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $63 49 1.31

More positions owned by Advisor Group Holdings

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPYM)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Advisor Group Holdings

Top funds holding Protagenic Therapeutics

DRW Holdings
FNY Investment Advisers
Citadel Advisors
Geode Capital Management
Raymond James Financial
Tower Research Capital
CoreCap Advisors
Advisor Group Holdings
CWM
Harbor Investment Advisory

View all funds holding Protagenic Therapeutics